InvestorsHub Logo
Followers 32
Posts 10384
Boards Moderated 0
Alias Born 04/20/2016

Re: loanranger post# 53610

Thursday, 01/28/2021 9:27:48 AM

Thursday, January 28, 2021 9:27:48 AM

Post# of 54031
LOL Weren't you the one crying the CBD gum was not in the grocery stores. Products usually take time, and with CBD quite a bit of legal and due diligence needed to be done.

Even with Serendipity Ice Cream, besides CVS, Walgreens and 7/11 all of who wanted to launch the ice cream it took 3-9 months to get the product in to rotation.

I believe CVS, Target and Walmart have also approved Tauri-Gum as a direct vendor.

The Stock Up Express is a division similar to Jet only more bulk sales, this is the first CBD product they have introduced. I would imagine that TauriGum will be displayed at the semi annual food shows they host for supermarkets.

I wrote long ago that Sysco felt the two biggest trends in the food space are non meat protein sources and CBD.

And for the 100th time, as great as retail sales could possibly be, it is the pharma element that could be the grand slam here.

That is not hype, that is a fact. But even though Tauriga first pharma gum is geared towards helping people with nausea from the effects of chemo, rather than treat a disease, drug trials are difficult. The nausea market is said to be a 7 billion dollar market. A CBD compound has already been approved by the FDA to treat on disease and the attorney that worked that process through is Tauriga's attorney. I bet there are many Universities and pharmacuetical companies that would love to partner with a trial. I know a little bit about trials due to my wife running trials at PFE and friends with high pharma positions. I don't think it will take a huge amount of money for these trials, but that is just a guess.

Funny, weren't you the one making fun that the gum wasn't in the grocery stores a while back. Now it seems the comment is snarky that in addition the stores a major distributor is taking on the gum.

No secret that I have supported and consulted the company since 2015. In fact, Bozo Berman use to remind us of that daily.

Whether the stock price is 2 cents, 15 cents or any price investors should do their own research, and while I have my opinions most people should look at this as a highly speculative.

Weren't you the one who said that you never saw a company get back to a listed status after Cowan Gutenski committed malpractice and fraud against the Company by concealing the PCAOB investigation for failure to rotate auditors. Well, they did get back to listed. And even though I was skeptical of CBD at first I am not now.

Looks like with just the Vistagen position Tauriga has the entire Cowan Settlement still and has made so much progress. Dilution is always an issue, just like it was in Vistagen but eventually certain investors saw the value in the portfolio was greater than the dilution.

Have A Great Day